Faculty in the News

Professor Fredrick Abbott published a story in The Capital Forum about Liquidia’s lawsuit against the FDA.

Read it here. 

Professor Michael Morley, Director of the Election Law Center, has been a go-to expert in the lead-up to the 2024 elections, including features on several media outlets:

• PolitiFact, "Text message shows Turnout the Vote offering “$200 to vote for Kamala Harris”
• Reuters, "Fact Check: Typo on display of Virginia voting equipment does not invalidate votes"
• AzMirror, "Final election results won’t be known tonight. It’s perfectly normal, and here’s why"
• BridgeMI, "Noncitizen facing felony charges after casting ballot in Michigan election"
• Inquirer, "Donald Trump makes false claims about ballots in Lancaster County in Truth Social post"
• The Hill, "Hurricane Helene aftermath poses election hurdles in critical battlegrounds"

Professor Michael Morley, Director of the Election Law Center, has been a go-to expert in the lead-up to the 2024 elections, including features on several media outlets:

• CNN "Last-minute challenges in battleground Pennsylvania target thousands of mail-in ballots"
• Fox 35 Orlando, "What happens with Amendments 3 & 4 after the election"
• Tampa Bay Times, "Hurricane damage effects on Florida election turnout unclear"

Professor Morley recently authored an article for The Conversation titled, “Florida and North Carolina are Making it Easier for People to Vote After the Hurricanes – But Some Risks Remain.”

Professor Morley was quoted in a Citizen Times article, "Presidential election is just five weeks away. How will Helene affect it in North Carolina?"

Professor Erin Ryan was recently interviewed for a Law360 article titled " Why A Tactic in the Youth Climate Change Battle is Risky.”

Professor Jay Kesten was recently quoted in a Newsweek article titled “Trump-Linked Crypto Venture Uses Web Privacy Service Linked to Russian Hackers.”

Professor Morley was quoted for a Bloomberg Law article, "Challenges to Biden Policies Fuel Supreme Court Summer Surge"

Professor Mason Marks was recently quoted in a Nature article titled ““FDA Rejects Ecstasy as a Therapy: What’s Next for Psychedelics?”

Professor Mason Marks was recently quoted in a Time article titled “The FDA Didn’t Approve MDMA. Is the Medical System Ready for Any Psychedelic?”